Octreotide Market Landscape: Analyzing Size, Share, and Future Innovations in Somatostatin Receptor-targeted Drugs
Octreotide, a somatostatin analog, has emerged as a cornerstone in the management of various neuroendocrine disorders, contributing to the evolution of the octreotide market. This therapeutic agent, originally developed for its ability to mimic the effects of somatostatin, finds application in treating conditions such as acromegaly, carcinoid syndrome, and certain types of tumors. This article … Read more